iifl-logo-icon 1

Biocon Ltd Share Price

358.25
(2.14%)
Jul 15, 2024|02:04:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open352
  • Day's High361.5
  • 52 Wk High373.85
  • Prev. Close350.75
  • Day's Low350.75
  • 52 Wk Low217.5
  • Turnover (lac)11,915.16
  • P/E389.33
  • Face Value5
  • Book Value91.91
  • EPS0.9
  • Mkt. Cap (Cr.)43,011.5
  • Div. Yield0.14
Loading...
  • Open356.8
  • Day's High361.65
  • Spot357.95
  • Prev. Close351.85
  • Day's Low351.45
  • ViewShort Covering
  • Market Lot2,500
  • OI(Chg %)-77,500 (-0.16%)
  • Roll Over%0.62
  • Roll Cost0.94
  • Traded Vol.92,27,500 (9.72%)
View More Futures

Biocon Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

352

Prev. Close

350.75

Turnover(Lac.)

11,915.16

Day's High

361.5

Day's Low

350.75

52 Week's High

373.85

52 Week's Low

217.5

Book Value

91.91

Face Value

5

Mkt Cap (₹ Cr.)

43,011.5

P/E

389.33

EPS

0.9

Divi. Yield

0.14

Biocon Ltd Corporate Action

11 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

23 May 2023

12:00 AM

AGM

Announcement Date: 23 May, 2023

arrow

16 May 2024

12:00 AM

Dividend

Dividend Amount: 0.5

Record Date: 05 Jul, 2024

arrow

Biocon Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Biocon Ltd SHAREHOLDING SNAPSHOT

15 Jul, 2024|02:27 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 20.27%

Foreign: 20.27%

Indian: 40.36%

Non-Promoter- 19.31%

Institutions: 19.31%

Non-Institutions: 19.73%

Custodian: 0.31%

Share Price

Biocon Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

600.3

600.3

600

600

Preference Capital

0

0

0

0

Reserves

10,315.7

7,492.6

7,307.1

6,937.3

Net Worth

10,916

8,092.9

7,907.1

7,537.3

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

1,738.2

2,028.4

1,988.4

2,419.2

yoy growth (%)

-14.3

2.01

-17.8

-6.51

Raw materials

-808.2

-798.3

-827.7

-1,049.4

As % of sales

46.49

39.35

41.62

43.37

Employee costs

-367.7

-390.2

-344.8

-408.6

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

139.7

358.8

388.5

305.8

Depreciation

-108.2

-103.5

-98

-136.1

Tax paid

-53.6

-78.3

-111.9

-67.3

Working capital

268.3

64.09

379.5

-311.6

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-14.3

2.01

-17.8

-6.51

Op profit growth

-80.44

9.26

-10.11

-46.23

EBIT growth

-60.99

-7.82

27.02

-43.18

Net profit growth

-69.3

-36.38

84.86

-54.07

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

14,755.7

11,174.2

8,184

7,143.1

6,300.5

Excise Duty

0

0

0

0

0

Net Sales

14,755.7

11,174.2

8,184

7,143.1

6,300.5

Other Operating Income

0

0

0

0

0

Other Income

865.5

375.9

212.7

267.1

228.9

Biocon Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,577.3

124.083,78,675.04867.60.865,536.9998.75

Cipla Ltd

CIPLA

1,512.05

32.871,22,092.681,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,539.3

76.441,20,480.265310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,175.15

34.281,18,217.41,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,719.45

26.171,12,137.091,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Biocon Ltd

Management

Register Office

Registrar Office

Chairperson

Kiran Mazumdar Shaw

Director

Ravi Mazumdar

Independent Director

Vijay Kumar Kuchroo

Independent Director

M Damodaran

Independent Director

Bobby Parikh

Company Sec. & Compli. Officer

Mayank Verma

Managing Director & CEO

SIDDHARTH MITTAL

Director

Eric Vivek Mazumdar

Independent Director

Naina Lal Kidwai

Independent Director

Peter John Bains

Additional Director

Atul Dhawan

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Biocon Limited is Indias largest and fully-integrated, innovation-led biopharmaceutical company. The Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in the year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind. In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International. Also in the same year, the company had received US funding for proprietary technologies. After a year, in 1990, Biocon had scaled up its in-house research programme, based on a proprietary solid substrate fermentation technology, from pilot to plant level. Biocons R&D and manufacturing facilities received ISO 9001 certification from RWTUV, Germany during the period of 1993. In the year 1994, the company had established the Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector. The commercial success of Biocons proprietary fermentation plant leads to a 3-fold expansion during the year 1996 and also in the same year, the company had leveraged its technology platform to enter biopharmaceuticals and statins. Biocon had spearheads initiatives in human healthcare in the year 1997 through a dedicated manufacturing facilit
Read More

Company FAQs

What is the Biocon Ltd share price today?

Down Arrow

The Biocon Ltd shares price on N/A is Rs.₹359.7 today.

What is the Market Cap of Biocon Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Biocon Ltd is ₹43185.58 Cr. as of 15 Jul ‘24

What is the PE and PB ratio of Biocon Ltd?

Down Arrow

The PE and PB ratios of Biocon Ltd is 389.33 and 3.86 as of 15 Jul ‘24

What is the 52 Week High and Low of Biocon Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Biocon Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Biocon Ltd is ₹217.5 and ₹374.4 as of 15 Jul ‘24

What is the CAGR of Biocon Ltd?

Down Arrow

Biocon Ltd's CAGR for 5 Years at 6.69%, 3 Years at -3.29%, 1 Year at 35.21%, 6 Month at 27.79%, 3 Month at 27.86% and 1 Month at 3.44%.

What is the shareholding pattern of Biocon Ltd?

Down Arrow

The shareholding pattern of Biocon Ltd is as follows:
Promoters - 60.64 %
Institutions - 19.31 %
Public - 19.73 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.